How to Invest in OpenAI Before the IPO: 4 Routes

OpenAI is one of the most talked-about companies on the planet. ChatGPT has over 1.2 billion weekly active users, revenue is running at roughly $20 billion a year, and the company raised $122 billion in its latest funding round at an $852 billion valuation. So it makes sense that people want to know how to invest in OpenAI before it goes public.

The problem is that there is no OpenAI stock to buy. OpenAI is a private company. You cannot look up a ticker symbol, place an order, and own a share. Every route to OpenAI exposure right now is indirect, and each one comes with trade-offs.

This guide breaks down every legal way for a US investor to get exposure to OpenAI. We will cover direct pre-IPO access for accredited investors, the ARK ETFs that hold OpenAI, Microsoft as a public proxy, and the real risks you need to understand before putting money in.

Why OpenAI Isn't Publicly Traded

OpenAI has never sold shares to the public. It operates as a private company with a complex structure that includes a nonprofit parent, a public benefit corporation, and a capped-profit subsidiary. That structure took years to build and is not easy to unwind.

OpenAI CEO Sam Altman confirmed in an interview with Fortune that OpenAI will not go public this year. He said the company has a lot of work still to do and cited AI safety concerns and the need to build the business further before facing public market pressures. That timeline had been discussed earlier, when OpenAI filed a confidential draft S-1 with the SEC, but Altman has since said it is not happening yet. Reports from the New York Times indicated OpenAI was leaning toward pushing the IPO into a later year.

Even with the delay, the filing is real. A confidential S-1 means OpenAI has submitted its financial details to the SEC for review, but has not made them public. It gives the company the option to move quickly if it decides to list. Reports suggested the IPO could value OpenAI at $1 trillion or more, which would make it the largest stock market debut in history.

So OpenAI stock does not exist yet. Anyone who tells you otherwise is selling something that is not registered or approved by the company. That includes the tokenized pre-IPO products you might see on crypto exchanges. Both OpenAI and Anthropic have issued warnings that unauthorized transfers of their shares are void and may violate US securities laws.

Direct Pre-IPO Access (Accredited Only)

The most direct way to own a piece of OpenAI before the IPO is through the secondary market. That means buying shares from an existing shareholder, usually an employee or an early investor who wants to cash out some of their position.

This route is limited to accredited investors. Under SEC rules, you need a net worth over $1 million (not counting your primary home), annual income over $200,000 or $300,000 jointly, or a qualifying professional credential like the Series 7, 65, or 82 license.

There is a critical detail about OpenAI that makes this harder than most pre-IPO deals. OpenAI does not allow direct stock transfers. You cannot put OpenAI shares in your own name. Access runs through a special purpose vehicle (SPV) or a forward purchase contract. The SPV holds the shares, and you own a piece of the SPV.

That means you are trusting the SPV structure, the platform that created it, and the legal documents behind it. OpenAI has specifically stated that unapproved SPVs do not have permission to hold its stock, and any transfer to an unapproved vehicle is considered void. If the company rejects the SPV, your investment could be worthless.

Here is the secondary market landscape for OpenAI exposure right now:

• ▸ Forge Global (FRGE): One of the largest private securities marketplaces, with a standard minimum of $100,000 per transaction. Forge handles institution-focused trades and charges 2% to 4% in fees. Some pooled funds through Forge have lower minimums starting around $5,000, but those come with additional fee layers.
• ▸ Hiive: Operates like a real-time order book for private stock. The minimum order is $25,000. Hiive is known for SpaceX and other high-demand names, and it offers both direct share purchases and opportunity funds.
• ▸ EquityZen: Acquired by Morgan Stanley. EquityZen is known for lower minimums, starting at $5,000 for select deals, with a standard minimum around $10,000. Transaction fees were cut to 2.5% after the Morgan Stanley deal. EquityZen bundles investor orders into SPVs.

The secondary market price for OpenAI units has traded near $714 per share, which is roughly 3% above the last primary round price of about $694 per share. The market cap implied by that secondary price sits near $881 billion. On a revenue basis, that works out to about 44 times OpenAI's roughly $20 billion run-rate revenue.

To be clear, most of these platforms have OpenAI inventory from time to time, but supply is limited. Employees and early investors are the sellers, and not all of them are willing to part with shares before the IPO.

ARK Venture Fund and Other Funds

If you are not an accredited investor, or if you want a more diversified approach, funds and ETFs are the most practical route to OpenAI exposure. The most notable one is Cathie Wood's ARK Venture Fund, which holds a direct stake in OpenAI.

The ARK Venture Fund has roughly 8.6% of its portfolio tied to OpenAI, worth about $69 million, according to Bloomberg Intelligence analysts James Seyffart and Francis Sharoon. That makes ARK the fund manager with the highest percentage of its portfolio riding on OpenAI. Fidelity holds more in absolute dollars, with an estimated $408 million position in its Contrafund alone, but that is just 0.2% of the fund.

ARK's publicly traded ETFs also carry OpenAI exposure. The ARK Innovation ETF (ARKK), ARK Blockchain & Fintech Innovation ETF (ARKW), and ARK Next Generation Internet ETF (ARKF) each hold roughly a 3% OpenAI position. ARK invested approximately $240 million in OpenAI across these three funds.

These ETFs trade on public exchanges. You can buy them through any brokerage account. There is no accreditation requirement, no minimum investment, and no lock-up. The trade-off is that OpenAI is only a small part of each fund, and the other holdings drive most of the performance.

Other ETFs with private market exposure include the ERShares Private-Public Crossover ETF (XOVR) and the KraneShares Artificial Intelligence & Technology ETF (AGIX). XOVR holds SpaceX exposure through an SPV and has been the first ETF to hold a pre-IPO position through to an actual IPO. AGIX took a direct stake in Anthropic that has run in the 4% to 5% range of net assets. These funds give you a diversified basket of private and public companies, with OpenAI as one component rather than the main event. Many of these funds also sit alongside the broader list of best investments ranked by risk-adjusted return.

Public Company Proxies

Before OpenAI goes public, there are a few public companies that give you indirect exposure. These are not pure plays. They are large businesses with their own risks and rewards, and OpenAI is only part of the story. All three trade as ordinary stocks in any brokerage account.

Microsoft (MSFT) is the most obvious proxy. Microsoft has invested billions in OpenAI and holds roughly 27% of the company's equity. Microsoft's Azure cloud platform is OpenAI's primary compute provider, and Microsoft Copilot is built on OpenAI's models. If OpenAI grows, Microsoft benefits through its equity stake, its cloud revenue, and its AI product lineup. But Microsoft is a $3 trillion company. Its stock price is driven by its entire business, not just OpenAI.

Nvidia (NVDA) is another proxy. Nvidia supplies the GPUs that OpenAI uses to train its models. OpenAI's massive compute spending flows directly to Nvidia's revenue. But Nvidia sells to hundreds of customers, and OpenAI is just one of them. Nvidia is also a $4 trillion-plus company, so even a multi-billion-dollar OpenAI contract is a small piece of the pie.

Amazon (AMZN) led OpenAI's most recent funding round alongside Nvidia and SoftBank. Amazon committed up to $50 billion, with $15 billion immediately available and the remaining $35 billion tied to conditions, including OpenAI completing an IPO or achieving AGI by an agreed deadline. Amazon Web Services also provides cloud infrastructure for OpenAI workloads.

These proxies are liquid. You can buy them in any brokerage account, sell them whenever the market is open, and hold them in retirement accounts. The trade-off is that you are not buying OpenAI. You are buying a large public company that happens to have a connection to OpenAI.

There is also a crop of smaller companies and funds that claim OpenAI exposure. Treat those with caution. Many hold SPVs that OpenAI has not approved, and some do not hold shares at all. The SEC has brought enforcement actions against pre-IPO platforms accused of misleading investors about SPV structures.

Risks of Pre-IPO Investing

OpenAI is an exciting company with a massive addressable market. But the risks of pre-IPO investing in OpenAI are real and need to be weighed carefully.

Illiquidity. Your money is locked up until OpenAI goes public, gets acquired, or allows a buyback. There is no guarantee any of those events will happen on any timeline. Altman has said a listing is off the table for now. Reports point to a later year, but even that is not certain. If the IPO slips by several more years, your capital is stuck.

Valuation uncertainty. The $852 billion valuation comes from a private funding round, not from public market price discovery. The secondary market trades near $881 billion, which is a 3% premium to the last round. That is a tight spread, which suggests the market is pricing OpenAI roughly in line with where SoftBank, Nvidia, and Amazon just put in serious money. But private valuations can be wrong. If the public market values OpenAI at $400 billion instead of $1 trillion, early investors could lose money.

SPV structure risk. OpenAI does not allow direct stock transfers. Your investment runs through an SPV or a forward contract. If the SPV is not approved by OpenAI, or if the legal structure has multiple layers, you could end up with a claim that is difficult to enforce. Anthropic and OpenAI have both issued statements that unapproved SPV transfers of their stock are void. If the company rejects the structure, your investment could be worthless.

No disclosure. OpenAI does not report quarterly earnings. You will not get the same level of financial detail that you would from a public company. You may go months or years without any meaningful news about revenue, costs, or strategy. That makes it hard to know whether your investment is on track.

Competition and cost risk. OpenAI faces intense competition from Anthropic, Google, and SpaceX's merged xAI entity. The AI arms race requires enormous spending on chips, data centers, and talent. OpenAI is still burning cash. Its API pricing is still higher than some competitors, which could limit adoption. If the company cannot control costs or hold market share, the IPO valuation could disappoint.

Regulatory risk. The SEC and state regulators are paying close attention to pre-IPO platforms, SPV structures, and tokenized private shares. If a platform you use is not properly registered or is not following disclosure rules, your investment could be at risk.

Pre-IPO investing is not a shortcut to IPO riches. It is a high-risk bet on a private company with limited disclosure, uncertain timing, and no guaranteed exit. Only invest money you can afford to lose, and if you are weighing several routes at once, run the numbers and check your asset allocation before committing capital.

Frequently Asked Questions

Can non-accredited investors buy OpenAI?

Not directly. Direct pre-IPO access through secondary marketplaces like Forge, Hiive, and EquityZen is limited to accredited investors. But non-accredited investors can get indirect OpenAI exposure through publicly traded ETFs like ARKK, ARKW, ARKF, and the ARK Venture Fund. These funds hold OpenAI stakes and trade on public exchanges with no accreditation requirement.

Is OpenAI going public?

OpenAI filed a confidential S-1 with the SEC, which is a real step toward an IPO. But CEO Sam Altman has said OpenAI will not go public this year. Reports point to a later date as a potential target, but no official date has been set. The IPO could be delayed further or accelerated depending on business conditions.

What is the best proxy for OpenAI stock?

Microsoft (MSFT) is the most direct public proxy because it holds roughly 27% of OpenAI's equity and provides its cloud infrastructure. Nvidia (NVDA) is a proxy for OpenAI's spending on chips and data centers. Both are large companies with many other business drivers. For a more concentrated bet on OpenAI specifically, ARK's ETFs or Venture Fund offer a higher percentage of exposure.

The Bottom Line

OpenAI is not publicly traded and will not be this year, according to CEO Sam Altman. But that does not mean you have zero options. Accredited investors can buy pre-IPO shares through secondary marketplaces, though the SPV structure adds risk and the shares are not held in your name. Non-accredited investors can get OpenAI exposure through ARK's ETFs or the ARK Venture Fund. Microsoft and Nvidia offer public proxies with their own trade-offs.

Each route has a different risk profile. Direct pre-IPO shares offer the most concentrated exposure, but they come with illiquidity, SPV structure risk, and no guarantee that OpenAI will approve the transfer. ETFs are liquid and easy to buy, but OpenAI is only a small slice of the fund. Microsoft and Nvidia are safe, liquid stocks, but they are not OpenAI.

If you decide to move forward, start by checking your accreditation status if you want direct access. If you are not accredited, look at the ETFs. Either way, run the numbers and make sure the potential upside justifies the risk. Compare your options, check your eligibility, and do not put in more than you can afford to lose.